<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The Icos Alumni: Where Are They Now?</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/11/18/the-icos-alumni-where-are-they-now/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/11/18/the-icos-alumni-where-are-they-now/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 01:49:51 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Abby Kliphardt</title>
		<link>http://www.xconomy.com/seattle/2009/11/18/the-icos-alumni-where-are-they-now/comment-page-1/#comment-112534</link>
		<dc:creator>Abby Kliphardt</dc:creator>
		<pubDate>Wed, 03 Mar 2010 15:19:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=48838#comment-112534</guid>
		<description>Nice article...good to see where my co-workers have ended.  I loved my time at ICOS and will always lament the loss of a great company that was a real family....</description>
		<content:encoded><![CDATA[<p>Nice article…good to see where my co-workers have ended.  I loved my time at ICOS and will always lament the loss of a great company that was a real family….</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: David Miller</title>
		<link>http://www.xconomy.com/seattle/2009/11/18/the-icos-alumni-where-are-they-now/comment-page-1/#comment-93727</link>
		<dc:creator>David Miller</dc:creator>
		<pubDate>Mon, 23 Nov 2009 19:54:40 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=48838#comment-93727</guid>
		<description>Nice work, Luke. Goes to prove that even though we might lose companies through acquisition we&#039;d really rather keep, it&#039;s not like everything connected with the company disappears. By my eye, the &quot;loss&quot; of Icos created at least a half-dozen new companies and significantly strengthened a dozen or more startups. A nice silver lining.</description>
		<content:encoded><![CDATA[<p>Nice work, Luke. Goes to prove that even though we might lose companies through acquisition we’d really rather keep, it’s not like everything connected with the company disappears. By my eye, the “loss” of Icos created at least a half-dozen new companies and significantly strengthened a dozen or more startups. A nice silver lining.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Luke Timmerman</title>
		<link>http://www.xconomy.com/seattle/2009/11/18/the-icos-alumni-where-are-they-now/comment-page-1/#comment-93313</link>
		<dc:creator>Luke Timmerman</dc:creator>
		<pubDate>Wed, 18 Nov 2009 19:04:31 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=48838#comment-93313</guid>
		<description>Johnny---Unfortunately, I never really got to know George very well because he had already left Icos by the time I started covering the company in 2001. But I made a point of meeting him at his home once a couple years ago when I was based in San Francisco. He wasn&#039;t in great health, but he was still sharp and very much curious about the latest happenings in biotech.  

I haven&#039;t heard the term Icosanoids from eicosanoid, but that made me laugh this morning. It sounds like something from Star Trek. Anybody know if this was also the inspiration for the term &quot;Immunoids&quot; for people who used to work at Immunex?</description>
		<content:encoded><![CDATA[<p>Johnny—Unfortunately, I never really got to know George very well because he had already left Icos by the time I started covering the company in 2001. But I made a point of meeting him at his home once a couple years ago when I was based in San Francisco. He wasn’t in great health, but he was still sharp and very much curious about the latest happenings in biotech.  </p>
<p>I haven’t heard the term Icosanoids from eicosanoid, but that made me laugh this morning. It sounds like something from Star Trek. Anybody know if this was also the inspiration for the term “Immunoids” for people who used to work at Immunex?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Johnny T. Stine</title>
		<link>http://www.xconomy.com/seattle/2009/11/18/the-icos-alumni-where-are-they-now/comment-page-1/#comment-93308</link>
		<dc:creator>Johnny T. Stine</dc:creator>
		<pubDate>Wed, 18 Nov 2009 18:48:25 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=48838#comment-93308</guid>
		<description>I actually loved our logo - very simple, but it just looked like fun.  
When George R. was recently asked by a reporter from an Everett newspaper about building Icos into a company like Amgen....he replied &quot;.....why would I stop there?&quot;.  With a leader like that, like George, one who inspires with energetic goals such as that mentioned - we could&#039;ve done it.  We had the tools and the ability to do just that.  We had great people who&#039;ve all proven themselves in places before and afterward.......but imagine what we could&#039;ve done behind the hopes of a great leader like George who set that tone....a CEO who knew all of our names, someone who would talk to you like you were a valued asset, a guy that empowered us via ownership.  Imagine what we could&#039;ve done.....because that&#039;s all we&#039;re left to do.

By the way- Luke - I prefer Icosanoids - a play on the word eicosanoid since we were primarily an inflammation company.  :-)</description>
		<content:encoded><![CDATA[<p>I actually loved our logo – very simple, but it just looked like fun.<br />
When George R. was recently asked by a reporter from an Everett newspaper about building Icos into a company like Amgen….he replied “…..why would I stop there?”.  With a leader like that, like George, one who inspires with energetic goals such as that mentioned – we could’ve done it.  We had the tools and the ability to do just that.  We had great people who’ve all proven themselves in places before and afterward…….but imagine what we could’ve done behind the hopes of a great leader like George who set that tone….a CEO who knew all of our names, someone who would talk to you like you were a valued asset, a guy that empowered us via ownership.  Imagine what we could’ve done…..because that’s all we’re left to do.</p>
<p>By the way- Luke – I prefer Icosanoids – a play on the word eicosanoid since we were primarily an inflammation company.  :-)</p>
]]></content:encoded>
	</item>
</channel>
</rss>

